PMDA — authorised 23 June 2021
- Marketing authorisation holder: AMGEN K.K.
- Status: approved
🇯🇵 Aimovig in Japan
PMDA authorised Aimovig on 23 June 2021
Marketing authorisation
Aimovig in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Aimovig approved in Japan?
Yes. PMDA authorised it on 23 June 2021.
Who is the marketing authorisation holder for Aimovig in Japan?
AMGEN K.K. holds the Japanese marketing authorisation.